Colgate-Palmolive sells oral care, personal care, home care and pet nutrition products in many countries. Its brands include Colgate toothpaste, Palmolive soaps and dish liquids, and Hill's pet food. Revenue comes from selling these everyday goods to supermarkets, pharmacies, mass retailers, online sellers and veterinary channels. The company relies on brand strength, steady repeat purchases and distribution in both developed and emerging markets.
The company reported revenue of $21.0 billion for the last twelve months. The three-year revenue growth rate is 4.3% a year. Profitability shows an operating margin of 14.9% and a return on invested capital of 34%. Net debt stands at 1.7 times EBITDA. Shareholders receive a dividend, yielding 2.2%. This gives an X-Ray Score of 57 out of 100.
52-wk range $74.55 – $99.33Volume 4,813,564Daily, split-adjusted
Vitals
Market cap$78.1B
52-week range$74.55 – $99.33
Volume (last day)4,813,564
P/E (TTM)38.6
EBIT / EV yield3.7%
Free-cash-flow yield4.9%
Dividend yield2.2%
Revenue (TTM)$21.0B
Net income (TTM)$2.0B
Operating margin14.9%
Return on capital34.4%
Debt incl. leases$7.8B
Cash & securities$1.4B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies that hold large long-term investments). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$87middle half of models $78 – $96
Fair−10.5% to fair value
Average of the 14 valuation models that pass our checks: multiples, discounted cash flow, dividend discount and earnings power value. A model more than 100% above or 60% below the price is left out as unrealistic. Model uncertainty is Medium, based on how far apart the models are. Undervalued or Overvalued means the gap to fair value is more than 17.5%.
Price $97
Undervalued < $74Fair $74 – $106Overvalued > $106
P/E multiple
$94
P/B multiple
$71
P/S multiple
$94
EV/EBITDA multiple
$91
EV/EBIT multiple
$84
EV/revenue multiple
$95
10-year DCF, EBITDA exit
$96
5-year DCF, EBITDA exit
$98
10-year DCF, revenue exit
$96
5-year DCF, revenue exit
$100
10-year DCF, growth exit
$60
5-year DCF, growth exit
$56
Dividend discount, stable
$108
Dividend discount, multi-stage · not used
$205
Earnings power value
$76
Growth the price implies
16.8%/yr
A model estimate, not a price target or recommendation. Inputs: risk-free 5.13%, equity risk premium 4.30% (Damodaran). How it works.
What this means
Average business, fairly priced
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Consumer Staples peers. Open a lens to see the numbers behind it.
Strong: 70 to 100Fair: 50 to 69Weak: under 50No score: not enough data
ValuationWeak
35/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield3.7%
Free-cash-flow yield4.9%
Fair value vs price0.9×
GrowthFair
61/100
Growing at a typical pace for its sector.
See the numbers →
Revenue growth (3y)4.3%
EPS growth (3y)7.3%
Growth consistency80%
ProfitabilityStrong
78/100
Earns high returns on the capital it uses.
See the numbers →
Return on invested capital34.4%
Operating margin14.9%
Gross profitability75.7%
Financial healthFair
55/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score5 / 9
Net debt / EBITDA1.7×
Interest cover12.3×
DividendsFair
51/100
Dividend is typical for its sector.
See the numbers →
Dividend yield2.2%
Dividends vs free cash flow44%
Dividend growth2.5%
Quarterly results: last 6 quarters
-3.0%Mar '25
+1.0%Jun '25
+1.9%Sep '25
+5.8%Dec '25
+8.4%Mar '26
+4.9%Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $5.4B, diluted EPS $0.86.
Other Household Products companies by X-Ray Score.
SWOT analysis: Colgate Palmolive Co
Strengthsinside the company
Return on invested capital is 34.4%, against a median of 15.1% for industry peers.
Operating margin of 14.9% is well above the 10.2% median of industry peers, a sign of pricing power or lower costs.
Operating profit covers interest 12x, so debt costs are a small drag.
Weaknessesinside the company
No clear weakness in the figures we track.
Opportunitiesvaluation and setting
Dividends use only 44% of free cash flow, which leaves room to raise them.
Price momentum is strong on the weekly and monthly signals (trends can reverse).
Threatsvaluation and setting
Trades at 38.3x earnings, 100% above the 19.1x median of industry peers, so the price already assumes better results.
Written by fixed rules from the figures on this page and the peer table below: filings, our fair value, the sector climate and the price trend. It summarises the data, it is not a forecast or advice.
Compare CL with peers and sector
Medians of 3 Household Products peers and of 28 Consumer Staples stocks in our universe.
Largest peers (X-Ray Score): KMB50, CHD47, CLX24.
Metric
CL
Peers
Sector
X-Ray Score (out of 100)
57
47
50
Valuation
35
–
53
Growth
61
30
48
Profitability
78
44
51
Financial health
54
–
46
Dividends
51
44
50
Sector leaders: highest X-Ray Score in Consumer Staples
CL ranks #9 of 29 in Consumer Staples and #1 of 4 in Household Products by X-Ray Score. A higher score is stronger on our five pillars; it is a ranking of facts, not a forecast.
Green means better than the peer median, red worse (only where a higher or lower figure is clearly better). A dash means too few companies report the figure. P/E, EV/EBITDA and price changes are not graded: a different level is not good or bad by itself.
Factor ratings for CL
Each factor is rated by where CL stands among the 29 Consumer Staples stocks in our universe.
Rating against the sector
Goodthe top third of these stocks
Averagethe middle third of these stocks
Badthe bottom third of these stocks
"Beats" is the share of those stocks it is ahead of.
Against its own history
The last columns set today's figure against the company's own median of its last five financial years:
▲ Betterbetter than its usual level
▼ Worseworse than its usual level
≈ In linewithin its usual range
For valuation factors Good means cheaper than most of the sector and Better means cheaper than usual for this company, which is not the same as a bargain.
In total: 9 Good · 7 Average · 7 Bad of 23Growth: 1 · 1 · 1Profitability: 3 · 2 · 0Financial strength: 1 · 2 · 1Valuation: 0 · 1 · 4Cash flow: 4 · 0 · 0Efficiency: 0 · 1 · 1
Factor
CL
Rating
Sector median
Own 5-year median
Against own history
Growth
Revenue growth, 3 years a year
+4.3%
Goodbeats 70%
+2.3%
–
–
Revenue growth, last year
+1.4%
Badbeats 30%
+2.2%
+3.3%
≈ In line
EPS growth, 3 years a year
+7.3%
Averagebeats 62%
+2.0%
–
–
Profitability
Gross margin
60.4%
Goodbeats 83%
38.7%
59.6%
≈ In line
Operating margin
14.9%
Averagebeats 57%
11.0%
19.1%
▼ Worse
Net margin
9.7%
Averagebeats 59%
6.9%
11.8%
▼ Worse
Return on invested capital
34.4%
Goodbeats 83%
15.2%
–
–
Return on equity
863.1%
Goodbeats 98%
18.6%
445.1%
▲ Better
Financial strength
Net debt / EBITDA
1.7x
Goodbeats 70%
2.0x
1.6x
≈ In line
Interest cover
12.3x
Averagebeats 52%
11.8x
14.6x
▼ Worse
Current ratio
1.03
Averagebeats 48%
1.04
1.09
≈ In line
Piotroski F-score
5 / 9
Badbeats 21%
6 / 9
–
–
Valuation
P/E ratio
38.3x
Badbeats 13%
25.0x
30.1x
▼ Worse
Price / book
330.9x
Badbeats 2%
4.5x
164.8x
▼ Worse
Price / sales
3.7x
Badbeats 23%
1.8x
3.7x
≈ In line
EV / EBITDA
22.5x
Badbeats 25%
15.2x
18.0x
▼ Worse
Free cash flow yield
4.9%
Averagebeats 56%
4.8%
4.6%
≈ In line
Cash flow
Free cash flow margin
18.3%
Goodbeats 83%
9.3%
15.8%
▲ Better
Cash from operations / net income
2.19
Goodbeats 85%
1.54
1.54
▲ Better
Free cash flow growth, 3 years a year
+25.0%
Goodbeats 82%
+11.0%
–
–
Accruals (lower is better)
−14.4%
Goodbeats 98%
−4.2%
–
–
Efficiency
Inventory turnover
3.8x
Badbeats 23%
5.3x
4.0x
≈ In line
Days sales outstanding
34 days
Averagebeats 55%
35 days
30 days
▼ Worse
These ratings compare companies with each other and describe the past; they are not a forecast, a recommendation or part of the X-Ray Score. A factor is left out when its data is missing or meaningless (for example a P/E on negative earnings). A dash in the history columns means fewer than three usable years.
Fundamentals checklist
● 7 Good · ● 6 Average · ● 3 Bad
Cash quality
Earnings backed by cashGood
Free-cash-flow yieldAverage
Risk models
Altman Z''Good
Piotroski F-ScoreBad
Growth
EPS growth (3y)Average
Free-cash-flow growth (3y)Good
Revenue growth (3y)Good
Growth consistencyAverage
Balance sheet
Current ratioAverage
Net debt / EBITDAGood
Interest coverAverage
Valuation
Fair value vs priceBad
EBIT / EV yieldBad
Profitability
Return on invested capitalGood
Operating marginAverage
Gross profitabilityGood
Each check is graded against the company's sector, not a fixed number. Checklist score 63/100.
Financials
FY21
FY22
FY23
FY24
FY25
Revenue
$17.4B
$18.0B
$19.5B
$20.1B
$20.4B
Operating income
$3.3B
$2.9B
$4.0B
$4.3B
$3.3B
Net income
$2.2B
$1.8B
$2.3B
$2.9B
$2.1B
Operating cash flow
$3.3B
$2.6B
$3.7B
$4.1B
$4.2B
Operating margin
19.1%
16.1%
20.5%
21.2%
16.2%
Free cash flow
$2.8B
$1.9B
$3.0B
$3.5B
$3.6B
Diluted EPS
$2.55
$2.13
$2.77
$3.51
$2.63
Fiscal years, from SEC filings.
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
92.39
Bullish
EMA 10
92.71
Bullish
SMA 20
89.29
Bullish
EMA 20
90.80
Bullish
SMA 50
89.26
Bullish
EMA 50
89.74
Bullish
SMA 100
90.07
Bullish
EMA 100
89.34
Bullish
SMA 200
88.77
Bullish
EMA 200
88.19
Bullish
Oscillators (daily)
RSI (14)
73.42
Bearish
MACD (12, 26)
1.88
Bullish
Momentum (12)
11.62
Bullish
Stochastic %K (14)
99.16
Bearish
Williams %R (14)
-0.84
Bearish
CCI (20)
156.2
Bearish
Pivot points (classic, last session)
S3
92.53
S2
93.54
S1
95.47
Pivot
96.48
R1
98.41
R2
99.42
R3
101.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.11 USD
Yield on today's price
2.17%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.5300
0.5300
0.5300
0.5200
0.5200
0.5200
0.5200
0.5000
0.5000
0.5000
0.5000
0.4800
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
The eight funds with the largest weight in CL among the ETFs we cover, from each fund's latest SEC Form N-PORT (quarter-end positions, so they can be months old). All ETFs.
CL stock splits
CL has split its stock 4 times since 1991. The latest was a 2-for-1 split on 16 May 2013.